Original ArticleTranslational OncologyMutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers
Translational Oncology
Under a Creative Commons license
open access
Keywords
Low-dose computed tomography
Lung cancer
MicroRNA-based liquid biopsy
Mutational load
Next-generation sequencing
Cited by (0)
Ms. Verri, Ms. Borzi, and Dr. Holscher equally contributed to this work.
Disclosure: Drs. Sozzi, Boeri, and Pastorino are coinventors for three patent applications licensed to Gensignia Life Sciences and regarding the miRNA signature disclosed in this article. The remaining authors declare no conflict of interest.
© 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.